Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Research Project: CMT Biomarkers and Outcome Measures
Dear Patients and Families affected by Charcot Marie Tooth Disease Type 2A, 2F, 1B and X, We wanted to reach out to you about your possible participation in a research…
Repurposing Drugs for CMT1A: An Encouraging Approach
…project underscores CMTA’s commitment to supporting cutting-edge research and fostering collaboration between the CMT community, clinicians, and industry experts. CMTA’s Strategy To Accelerate Research (STAR) initiatives continue to be vital…
MDA and CMTA Fund Grant to Study Gene Therapy in Charcot-Marie-Tooth Disease
…core of the CMTA’s STAR (Strategy to Accelerate Research) approach to finding treatments for various types of CMT, so we are very pleased to announce today the first research project…
What is STAR?
…vision is poised to become reality as STAR pushes the Charcot-Marie-Tooth research forward at an ever-increasing speed. One of the first ways that the CMTA accelerates CMT research is by…
Toxic Medications List For Patients with Charcot-Marie-Tooth Disease
…shaping and delivering the CMTA’s research strategies. The CMTA currently has more than 50 active research projects, including sponsored research grants with academic labs and pre-clinical testing studies with biotech/pharma…
CMTA 2023 Annual Report Download
…The active involvement of our community through the Patients as Partners in Research platform is crucial—research cannot advance without the community at its core. SPONSORED RESEARCH PROJECTS In 2023, nine…
CMTA 2023 Annual Report Download
…Research Funding since 1983 CMTA Centers of Excellence Patients as Partners in Research 30+ Active Research Projects 40+ Research Partners 83 CMTA Branch Meetings $383,722 Raised by WALK & CYCLE…
2023 CMTA Annual Report
…The active involvement of our community through the Patients as Partners in Research platform is crucial—research cannot advance without the community at its core. SPONSORED RESEARCH PROJECTS In 2023, nine…
Gene Replacement Therapy in CMT4 Subtypes
…of accelerating gene replacement therapies for CMT, underscoring our leadership in this critical area of research,” said Katherine Forsey, PhD, CMTA Chief Research Officer. “This investment in gene replacement therapy…
CMTA Report_Winter 2024 – STAR Special Edition_Download
…REPORT 1 A LETTER FROM SUE, OUR CEO Chief Research Officer, Katherine Forsey, PhD at CMTA’s 2024 Patient and Research Summit in Denver, CO FROM PATIENTS TO RESEARCH: CMTA’S iPSC…